Clinical trial
A Retrospective Study of Extremity Osteosarcoma Patients Who Recieved Intra-arterial Limb Infusion of Cisplatin During Neoadjuvant Chemotherapy
NCT03909776 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Study of Extremity Osteosarcoma Patients Who Recieved Intra-arterial Limb Infusion of Cisplatin During Neoadjuvant Chemotherapy
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2019
- Completion date
- April 8, 2019
- Enrollment
- 99 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
event-free survival, local-recurrence free survival, overall survival, pathological response